Hayden Panettiere Death Investigation: Fentanyl-Laced Oxycodone Reports and Her History of Addiction

Last updated: September 20, 2026

Table of contents

1. What Happened to Hayden Panettiere?
2. Was Fentanyl-Laced Oxycodone Involved in Hayden Panettiere’s Death?
3. Hayden Panettiere’s History With Opioids and Alcohol Began Years Earlier
4. Postpartum Depression, Opioid Use and Alcohol Became Intertwined
5. Her Alcohol Use Eventually Produced Serious Physical Consequences
6. “Save the Cheerleader”: A Life We Couldn’t Save From Addiction
7. Why Counterfeit Oxycodone Presents a Different Risk From Pharmacy-Dispensed Oxycodone
8. CDC Research Shows Counterfeit Pills Became Increasingly Common in Overdose Deaths
9. How Fentanyl Causes a Fatal Opioid Overdose
10. How to Reduce the Risk of an Opioid Overdose
11. Research Supports Ongoing Medical Treatment for Opioid Use Disorder
12. What Hayden Panettiere’s History Shows About Addiction
13. When Opioid or Alcohol Use Requires Medical Help
14. Frequently Asked Questions
15. What was Hayden Panettiere addicted to?
16. Did Hayden Panettiere die from fentanyl?
17. Did Hayden Panettiere overdose on oxycodone?
18. Can counterfeit oxycodone contain fentanyl?
19. Why is fentanyl dangerous in counterfeit pills?
20. Can naloxone reverse a fentanyl overdose?
21. References

Updated September 20, 2026: Hayden Panettiere died on August 16 at age 36 after she was found unresponsive at an apartment in Greenville, South Carolina. The investigation now includes the Drug Enforcement Administration and inquiries in Los Angeles into drugs she may have obtained before her death. Sources familiar with the investigation have told reporters that authorities are examining what was described as counterfeit oxycodone and whether fentanyl was involved, while the Greenville County Coroner’s Office has said that toxicology remains pending and has not yet issued an official cause or manner of death.¹²

The investigation has renewed attention to a history Panettiere had already described publicly. Beginning in adolescence, she said she was exposed to pills by an adult working around her career, later developed problems with opioids and alcohol, experienced postpartum depression, reached a point where alcohol was producing serious physical consequences, and eventually entered prolonged inpatient treatment. Those facts do not establish what caused her death. They do provide documented context for understanding how substance use developed across different periods of her life and why reports involving counterfeit oxycodone require particular attention in a drug supply increasingly affected by illicit fentanyl.³⁴

What Happened to Hayden Panettiere?

First responders were dispatched to the Judson Mill Lofts in Greenville at approximately 1:58 p.m. on August 16 after Panettiere was found unresponsive. Police arrived while emergency personnel were administering CPR and other lifesaving measures, and she was pronounced dead at 2:31 p.m. Greenville dispatch audio referred to a possible overdose while the emergency response was underway. Coroner Mike Ellis subsequently said that an autopsy found no visible injuries or trauma that appeared to have contributed to her death, and preliminary findings did not indicate foul play or suspicious circumstances. Her official cause and manner of death were deferred pending toxicology and additional testing.¹

The investigation widened during the following weeks. The Los Angeles Times reported on September 14 that DEA agents and local investigators had questioned several people about Panettiere’s death and were examining whether she had obtained nonprescription pills from a Los Angeles-area dealer. Sources familiar with the investigation described counterfeit oxycodone as a focus of the inquiry. Authorities were attempting to establish what she obtained, who supplied it and whether the substance contributed to her death.²

Panettiere’s on-and-off partner Brian Hickerson and his brother were present at the Greenville apartment when she was found unresponsive. A police report said Hickerson showed an officer a bag containing medications Panettiere was taking, and People reported in September that Hickerson had met with DEA investigators. He had not been identified as a suspect in Panettiere’s death at the time of that reporting.⁵

Was Fentanyl-Laced Oxycodone Involved in Hayden Panettiere’s Death?

Current reporting supports an investigation into counterfeit oxycodone and possible fentanyl exposure, but toxicology has not yet established that either drug caused Panettiere’s death. The distinction is medically important because finding a person in cardiac arrest identifies the immediate emergency rather than the disease, drug exposure or other event that produced it. Toxicology can identify drugs and metabolites present in the body, while the coroner must interpret those results together with the autopsy, medical history, scene evidence and investigative findings before assigning a cause and manner of death.¹

The counterfeit-oxycodone line of investigation nevertheless fits a documented change in the illicit U.S. drug supply. Counterfeit pills are manufactured to resemble legitimate medications, including oxycodone tablets, while containing substances that were never disclosed to the buyer. Illegally manufactured fentanyl has become especially important because it is a highly potent synthetic opioid and because the amount contained in an illicit tablet cannot be inferred from the tablet’s appearance.⁶

Hayden Panettiere’s History With Opioids and Alcohol Began Years Earlier

Panettiere first spoke extensively about her opioid and alcohol addiction in 2022. She said her exposure to drugs began at approximately 15, when someone working around her career began giving her what she called “happy pills” before red-carpet appearances so she would appear energetic during interviews. She said she did not understand at the time that being given the pills was inappropriate or how drug use could develop afterward. As she became older, she described drinking and using opioids while maintaining enough control to continue working, even as substance use outside the set became increasingly difficult to manage.³

Her account did not describe a single event that caused addiction. It described repeated exposure followed by a progression in which opioids and alcohol assumed a larger role in her daily life. That distinction is consistent with the medical understanding of substance use disorder, which develops through interactions among drug exposure, reinforcement, individual vulnerability, mental health, physical pain, stress and environment. A person’s ability to work during part of that progression does not exclude a substance use disorder; Panettiere herself said that maintaining control while filming concealed how severe the problem had become elsewhere in her life.³

Postpartum Depression, Opioid Use and Alcohol Became Intertwined

After the birth of her daughter Kaya in 2014, Panettiere experienced postpartum depression. She later described that period as one in which depression, physical pain and substance use overlapped. She did not drink during pregnancy, according to her account, but returned to alcohol afterward and began using it privately as her emotional condition deteriorated. Opioids were also part of her substance use during these years.³

Panettiere’s experience should not be reduced to a claim that postpartum depression caused her addiction. Depression and substance use disorders can occur together, and each can complicate assessment and treatment, but their relationship differs from person to person. In Panettiere’s own account, postpartum depression formed part of a broader period that already included an established history of drug and alcohol use, professional pressure, pain and worsening dependence.

Her role on Nashville added another unusual element. Panettiere played Juliette Barnes, whose storylines included postpartum depression, alcoholism and problems involving pills. She later said that performing material resembling events in her own life became difficult because the separation between the character’s experiences and her circumstances outside filming had narrowed. The relevance of that period lies in what Panettiere herself disclosed about her addiction rather than in treating a television storyline as evidence about her medical condition.

Her Alcohol Use Eventually Produced Serious Physical Consequences

By the later stages of her alcohol addiction, Panettiere said she would wake with tremors and needed alcohol to function. She developed jaundice and required hospitalization, and physicians warned that her liver was in danger. In her 2026 memoir, This Is Me: A Reckoning, she described a physician telling her that continued drinking could leave her dead within five years. She entered an inpatient rehabilitation program for approximately eight months in 2020 and later described severe withdrawal, including tremors, insomnia and auditory disturbances during that period.³⁴

The sequence is relevant because severe alcohol dependence changes the medical risk of stopping as well as continuing. Alcohol withdrawal can cause seizures, delirium and other complications in people with substantial physiological dependence, while continued heavy use can damage the liver, cardiovascular system, gastrointestinal system and nervous system. Panettiere’s account of jaundice, withdrawal symptoms and prolonged treatment describes addiction after it had moved beyond intermittent intoxication into a condition with serious physical effects.

She subsequently spoke publicly about recovery, trauma therapy and the work required to remain sober. Her disclosures also showed why recovery should not be presented as a single completed event. Substance use disorder is commonly managed over time, with continuing attention to relapse risk, psychiatric symptoms, relationships and the circumstances that previously supported drug or alcohol use.

“Save the Cheerleader”: A Life We Couldn’t Save From Addiction

For millions of viewers, Hayden Panettiere will always be connected to the line that defined the first season of Heroes: “Save the cheerleader, save the world.” Years later, the phrase carries a different weight. Panettiere survived years of opioid and alcohol addiction, serious physical consequences, treatment, relapse risk and the private struggle of trying to recover while much of her life remained public. Whatever toxicology ultimately establishes about her death, her history shows how addiction can persist behind fame, professional success and periods of apparent stability. The tragedy is not that people failed to recognize a television hero. It is that a real person spent years fighting a disease that can remain dangerous even after someone has asked for help, entered treatment and tried to rebuild her life.

Why Counterfeit Oxycodone Presents a Different Risk From Pharmacy-Dispensed Oxycodone

Oxycodone is a prescription opioid used clinically for pain, while fentanyl is a substantially more potent synthetic opioid used medically in carefully controlled circumstances. Illicit fentanyl presents a different problem because it can be incorporated into powders and counterfeit tablets without the person taking the drug knowing either the substance or dose. The Centers for Disease Control and Prevention states that most fentanyl-related harm in the United States is associated with illegally manufactured fentanyl rather than pharmaceutical fentanyl.⁶

A counterfeit oxycodone tablet may reproduce the shape, color and markings of a pharmaceutical pill closely enough that visual inspection cannot establish its contents. The uncertainty extends beyond whether fentanyl is present. Illicit pills can contain different fentanyl concentrations, fentanyl analogues, xylazine, illicit benzodiazepines or other substances, and tablets from the same general supply need not contain identical amounts.

Research led by emergency physician Rachel S. Wightman, MD, of Brown University’s Alpert Medical School examined 1,176 counterfeit prescription pills seized by law enforcement in Rhode Island between 2017 and 2022. Among counterfeit tablets marked as oxycodone and tested in 2022, 149 of 150 contained fentanyl. The researchers also found xylazine in 137 pills, 135 of which were counterfeit oxycodone tablets, and nearly all of the xylazine-positive pills also contained fentanyl.⁷

Those figures describe pills seized and tested in Rhode Island and should not be converted into a national probability for every counterfeit oxycodone tablet. Their value lies in demonstrating what investigators actually found in a defined drug supply: tablets represented as a familiar prescription opioid frequently contained fentanyl and sometimes contained additional drugs that the tablet markings did not disclose.

CDC Research Shows Counterfeit Pills Became Increasingly Common in Overdose Deaths

CDC researchers Julie O’Donnell, PhD, Lauren Tanz, ScD, and colleagues examined overdose deaths using the State Unintentional Drug Overdose Reporting System. Among jurisdictions with complete data, the percentage of overdose deaths with evidence of counterfeit-pill use increased from 2.0% in July through September 2019 to 4.7% in October through December 2021. In western jurisdictions, the proportion rose from 4.7% to 14.7%. Illicitly manufactured fentanyl was involved in 93% of deaths where counterfeit-pill use was documented.⁸

Counterfeit oxycodone accounted for a substantial share of those cases. More than half of the deaths with evidence of counterfeit-pill use involved evidence of counterfeit oxycodone alone, and another group involved both counterfeit oxycodone and counterfeit alprazolam. The researchers also found that people who died with evidence of counterfeit-pill use were younger on average and more likely to have a documented history of prescription-drug misuse than people whose overdose deaths did not contain such evidence.⁸

The national overdose picture has improved since the period covered by that study. CDC provisional data estimate 69,973 U.S. drug-overdose deaths during 2025, down almost 14% from 81,313 in 2024, while estimated opioid-involved deaths declined from 55,296 to 44,564. Counterfeit fentanyl pills nevertheless remain widely available. The DEA reported seizing more than 47 million fentanyl-containing counterfeit pills during 2025, with seizures occurring across all 50 states and the District of Columbia.^{9 10}

How Fentanyl Causes a Fatal Opioid Overdose

Fentanyl activates opioid receptors involved in pain, sedation and respiratory control. In an overdose, opioid effects can suppress the brain’s drive to breathe until breathing becomes slow, shallow or absent. Oxygen levels then fall, which can injure the brain and other organs and eventually lead to cardiac arrest. The danger of an illicit fentanyl-containing tablet comes partly from the person’s inability to know the drug concentration before taking it.⁶

Signs of opioid overdose can include unconsciousness or inability to wake, slow or shallow breathing, choking or gurgling sounds, blue or discolored lips or nails, a limp body and very small pupils. The CDC recommends treating a suspected opioid overdose as an emergency: administer naloxone if it is available and call 911. Naloxone can temporarily reverse the opioid effect that suppresses breathing, including overdoses involving fentanyl, and additional doses may sometimes be required when the person remains unresponsive.¹¹

How to Reduce the Risk of an Opioid Overdose

The counterfeit-pill problem changes the assumptions a person can safely make about a drug obtained outside normal medical channels. A tablet represented as oxycodone does not become pharmaceutical oxycodone because it has the correct color, imprint or shape. Prescription medication should come from a licensed pharmacy for the person to whom it was prescribed. Pills obtained through dealers, social contacts or unregulated online sources can contain drugs that are absent from the label or from what the seller claims to be providing.⁶¹⁰

Prevention also requires recognizing substance use before a medical emergency occurs. Escalating opioid use, repeated unsuccessful attempts to stop, withdrawal, strong cravings, continued use despite physical or psychological harm and increasing time spent obtaining or recovering from drugs are reasons for a clinical assessment. Alcohol dependence requires particular caution because abrupt withdrawal after sustained heavy use can become medically dangerous.

A previous period of abstinence does not remove future overdose risk. Loss of opioid tolerance can make a return to a previously used amount more dangerous, while an illicit supply containing fentanyl adds uncertainty about the dose being taken. People with a history of opioid use disorder therefore require treatment that addresses the disorder itself rather than relying only on short-term withdrawal management.

Research Supports Ongoing Medical Treatment for Opioid Use Disorder

A National Institutes of Health-funded cohort study led by Marc R. Larochelle, MD, MPH, followed 17,568 Massachusetts adults who survived a nonfatal opioid overdose. During the following year, methadone treatment was associated with a 59% reduction in opioid-related mortality and buprenorphine with a 38% reduction compared with people who did not receive medication for opioid use disorder. Because the research was observational, those figures describe associations rather than proving that medication alone produced the entire difference, but the findings add to a substantial body of evidence supporting medications for opioid use disorder.¹²

Nora D. Volkow, MD, director of the National Institute on Drug Abuse, has repeatedly emphasized that effective medications for opioid addiction remain underused despite evidence that they can reduce mortality. Withdrawal management can stabilize someone through the acute period after stopping opioids, while continuing treatment may include buprenorphine, methadone or naltrexone together with psychiatric care, behavioral treatment and follow-up appropriate to the individual.¹²

What Hayden Panettiere’s History Shows About Addiction

Panettiere’s public account spans more than a decade. She described early exposure to pills during adolescence, increasing opioid and alcohol use as she became older, postpartum depression, escalating alcohol dependence, serious liver problems, hospitalization, prolonged inpatient treatment and subsequent recovery work. That history provides a more accurate picture of substance use disorder than a narrative in which one decision suddenly produces severe addiction. Her own chronology shows accumulation: repeated drug exposure, reinforcement, psychological distress, physical dependence and periods in which functioning in one part of life coexisted with severe problems elsewhere.³⁴

Her death now sits within a separate investigation involving possible counterfeit oxycodone and fentanyl. Toxicology will determine whether those substances were present and help the coroner determine their medical significance. The broader prevention evidence does not depend on that final finding. Counterfeit prescription pills containing illicit fentanyl are well documented in laboratory testing, law-enforcement seizures and fatal-overdose surveillance, and people with opioid use disorder have evidence-based treatment options that reduce the risk of subsequent death.⁷⁸¹²

When Opioid or Alcohol Use Requires Medical Help

Someone who cannot stop using opioids or alcohol despite harm, develops withdrawal symptoms, returns repeatedly to use after trying to stop, or has already experienced an overdose should be medically assessed. We provide medically supervised detoxification and treatment planning for opioid, alcohol and other substance use disorders. A suspected overdose requires emergency care; call 911 rather than attempting to manage the situation through a treatment facility.

Frequently Asked Questions

What was Hayden Panettiere addicted to?

Panettiere publicly described addiction involving opioids and alcohol. She said substance use began during adolescence and became progressively more difficult to control as she grew older, while postpartum depression and other personal and medical problems overlapped with later periods of heavy use.³

Did Hayden Panettiere die from fentanyl?

The Greenville County Coroner had not officially confirmed fentanyl as a cause of death as of September 15, 2026. Investigators are examining reports involving counterfeit oxycodone and possible fentanyl exposure, but toxicology remains pending.¹²

Did Hayden Panettiere overdose on oxycodone?

Emergency dispatch audio referred to a possible overdose, and investigators are examining what was described as counterfeit oxycodone. An official determination that oxycodone caused or contributed to her death has not yet been released.¹²

Can counterfeit oxycodone contain fentanyl?

Yes. Counterfeit tablets designed to resemble oxycodone have repeatedly tested positive for illicit fentanyl. In a Rhode Island study published in JAMA, 149 of 150 counterfeit oxycodone pills tested in 2022 contained fentanyl, although those seizure data should not be interpreted as a national prevalence estimate.⁷

Why is fentanyl dangerous in counterfeit pills?

Illicit fentanyl is highly potent and can suppress breathing during an overdose. A counterfeit pill provides no reliable pharmaceutical control over which drug is present or how much of it the tablet contains, so its appearance cannot establish the dose or composition.⁶

Can naloxone reverse a fentanyl overdose?

Naloxone can reverse an opioid overdose involving fentanyl when administered in time. The CDC advises giving naloxone when opioid overdose is suspected and calling 911 immediately because its effect is temporary and additional emergency care may be required.¹¹

References

1. Medley L. “Greenville Co. Coroner Provides Update on Toxicology Report in Hayden Panettiere’s Death.” FOX Carolina. September 14, 2026. Greenville County Coroner and police reporting on the death investigation, autopsy and pending toxicology.
2. Winton R. “Hayden Panettiere Death Probe Focusing on Illegal Pills From L.A. Dealer.” Los Angeles Times. September 14, 2026. Reporting on the DEA investigation and suspected counterfeit oxycodone.
3. Kirkpatrick E. “Hayden Panettiere on ‘Cycle of Self-Destruction’ Caused by Opioid and Alcohol Addiction.” Vanity Fair. July 6, 2022. Based on Panettiere’s disclosures concerning early pill exposure, opioid and alcohol addiction, postpartum depression, jaundice and treatment.
4. People. “Hayden Panettiere Says Doctor Warned She’d Be ‘Dead Within Five Years’ If She Didn’t Stop Drinking.” 2026. Reporting based on Panettiere’s memoir This Is Me: A Reckoning.
5. People. “Hayden Panettiere’s Boyfriend Brian Hickerson Met With DEA as Death Investigation Remains Ongoing.” September 2026.
6. Centers for Disease Control and Prevention. “Fentanyl.” National Center for Injury Prevention and Control. Updated June 9, 2025.
7. Wightman RS, Chadronet T, Volpe B, Hallowell BD, Nolan LA, Gallagher GR. “Substances in Counterfeit Prescription Pills Seized by Law Enforcement, 2017–2022.” JAMA. 2024;331(21):1860–1862. doi:10.1001/jama.2024.6161.
8. O’Donnell J, Tanz LJ, Miller KD, et al. “Drug Overdose Deaths with Evidence of Counterfeit Pill Use — United States, July 2019–December 2021.” MMWR Morbidity and Mortality Weekly Report. 2023;72:949–956. doi:10.15585/mmwr.mm7235a3.
9. Centers for Disease Control and Prevention, National Center for Health Statistics. “U.S. Overdose Deaths Decrease for Third Consecutive Year in 2025.” May 13, 2026.
10. U.S. Drug Enforcement Administration. “Counterfeit Pills Fact Sheet: One Pill Can Kill.” Data updated January 2026.
11. Centers for Disease Control and Prevention. “Lifesaving Naloxone.” Updated June 11, 2025.
12. Larochelle MR, Bernson D, Land T, et al. “Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study.” Annals of Internal Medicine. 2018;169(3):137–145. doi:10.7326/M17-3107. NIH/NIDA-funded research.